Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Snynf crawled time : 12:30 save search
Nucleai Unveils Breakthrough AI Spatial Biomarker Advancements at AACR 2024 with the Potential to Transform Cancer Diagnostics and Treatments
Published: 2024-04-05 (Crawled : 12:30) - biospace.com/
SNYNF | News | $94.25 1.67% -2.18% 480
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: -1.81%
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: -3.44%
H: 0.0%
C: 0.0%
biomarker cancer diagnostics potential
Merck’s Corporate Venture M Ventures Arm Backs Nucleai to Advance Its First-in-class Spatial AI Biomarker in Active Clinical Enrollment
Published: 2024-04-03 (Crawled : 12:30) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
arm active biomarker
Sanders Blasts Novo Nordisk for ‘Outrageous’ Price of Ozempic, Wegovy
Published: 2024-03-28 (Crawled : 12:30) - biospace.com/
SNYNF | News | $94.25 1.67% -2.18% 480
|
Health Technology
|
| O: -1.17%
H: 0.0%
C: -0.89%
JNJ | News | $149.56 0.3% -0.17% 6.9M
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: 0.0%
wegovy
COPD Market Poised for ‘Paradigm Shift’ with Potential Approvals in 2024: GlobalData
Published: 2024-03-27 (Crawled : 12:30) - biospace.com/
SNYNF | News | $94.25 1.67% -2.18% 480
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
copd potential market
Mirador Therapeutics Launches to Accelerate the Next Generation of Precision Medicines for Immune-mediated Diseases
Published: 2024-03-21 (Crawled : 12:30) - biospace.com/
SNYNF | News | $94.25 1.67% -2.18% 480
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
precision therapeutics
Avenacy Announces Launch of Furosemide for Injection in the U.S. Market
Published: 2024-03-20 (Crawled : 12:30) - biospace.com/
SNYNF | News | $94.25 1.67% -2.18% 480
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: 0.03%
H: 0.0%
C: 0.0%
injection market
Innovent Announces 2023 Annual Results and Business Updates
Published: 2024-03-20 (Crawled : 12:30) - biospace.com/
SNYNF | News | $94.25 1.67% -2.18% 480
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: 0.03%
H: 0.0%
C: 0.0%
business results
Endeavor BioMedicines Appoints Enoch Kariuki, Pharm.D. as President and Vishaal Turakhia as Chief Financial Officer
Published: 2024-03-14 (Crawled : 12:30) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
financial
Graviton Bioscience Announces Strategic Investment from Sanofi to Advance Development of the Next Generation of Selective ROCK2 Inhibitors
Published: 2024-02-01 (Crawled : 12:30) - prnewswire.com
SNYNF | News | $94.25 1.67% -2.18% 480
|
Health Technology
|
| O: -4.37%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: -5.26%
H: 0.0%
C: 0.0%
MGTX | $4.93 -1.79% -2.03% 160K
|
Health Technology
|
| O: 1.81%
H: 0.0%
C: -1.13%
bioscience sanofi
Medison Pharma Announces Agreement with Regeneron Pharmaceuticals to Commercialize Libtayo® (cemiplimab) in Multiple Countries
Published: 2024-01-08 (Crawled : 12:30) - prnewswire.com
SNYNF | News | $94.25 1.67% -2.18% 480
|
Health Technology
|
| O: 2.07%
H: 0.48%
C: 0.48%
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: 1.16%
H: 0.0%
C: 0.0%
REGN | News | $907.32 0.8% 0.74% 220K
|
Health Technology
|
| O: -2.54%
H: 1.53%
C: 1.45%
libtayo pharma pharmaceuticals agreement
XOMA Names Owen Hughes as Chief Executive Officer and Appoints Jack L. Wyszomierski as Chairman of the Board of Directors
Published: 2024-01-08 (Crawled : 12:30) - globenewswire.com
SNYNF | News | $94.25 1.67% -2.18% 480
|
Health Technology
|
| O: 2.07%
H: 0.48%
C: 0.48%
SITE | $162.65 3.6% 0.0% 200K
|
Distribution Services
|
| O: -1.03%
H: 2.25%
C: 2.16%
XOMA | $26.09 1.05% 1.26% 12K
|
Health Technology
|
| O: 0.43%
H: 4.52%
C: 4.05%
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: 1.16%
H: 0.0%
C: 0.0%
EXEL | $23.29 1.84% 1.82% 1.9M
|
Health Technology
|
| O: -12.39%
H: 10.85%
C: 10.71%
jack
Merck KGaA’s BTK Inhibitor Fails Phase III Multiple Sclerosis Studies
Published: 2023-12-06 (Crawled : 12:30) - biospace.com/
SNYNF | News | $94.25 1.67% -2.18% 480
|
Health Technology
|
| O: -2.77%
H: 0.49%
C: 0.49%
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: 0.0%
merck sclerosis
Diabetes Management Apps Market to Record an Exponential CAGR of 24.4% by 2031 - Exclusive Report by InsightAce Analytic
Published: 2023-12-05 (Crawled : 12:30) - prnewswire.com
SNYNF | News | $94.25 1.67% -2.18% 480
|
Health Technology
|
| O: 0.27%
H: 0.12%
C: 0.12%
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
BEAT | $2.04 2.0% 1.96% 29K
|
Health Technology
|
| O: 0.0%
H: 2.04%
C: -1.36%
management report diabetes market
Madrigal Pharmaceuticals Appoints Carole Huntsman as Chief Commercial Officer
Published: 2023-11-10 (Crawled : 12:30) - globenewswire.com
SNYNF | News | $94.25 1.67% -2.18% 480
|
Health Technology
|
| O: -1.28%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
MDGL | $218.38 2.29% 2.15% 350K
|
Health Technology
|
| O: 1.3%
H: 0.97%
C: 0.52%
pharmaceuticals commercial
Kymera Therapeutics Announces First Patient Dosed in Phase 2 Hidradenitis Suppurativa Clinical Trial of KT-474
Published: 2023-10-27 (Crawled : 12:30) - biospace.com/
SNYNF | News | $94.25 1.67% -2.18% 480
|
Health Technology
|
| O: -18.18%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: -15.73%
H: 0.0%
C: 0.0%
KYMR | $35.71 3.96% 3.78% 440K
|
Health Technology
|
| O: 0.78%
H: 0.0%
C: -5.43%
kt-474 trial therapeutics phase 2
3T Biosciences Expands Leadership Team With Bryan Irving, Ph.D., as Chief Scientific Officer to Progress Tumor-specific Therapies to Clinic
Published: 2023-10-25 (Crawled : 12:30) - biospace.com/
SNYNF | News | $94.25 1.67% -2.18% 480
|
Health Technology
|
| O: 0.4%
H: 1.29%
C: 1.29%
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: 1.43%
H: 0.64%
C: -0.09%
UCB Scores Two FDA Approvals; Intellia Makes Gene Editing History
Published: 2023-10-20 (Crawled : 12:30) - biospace.com/
SNYNF | News | $94.25 1.67% -2.18% 480
|
Health Technology
|
| O: -3.95%
H: 0.0%
C: -0.72%
PRGO | $30.49 1.43% 1.41% 840K
|
Health Technology
|
| O: 0.2%
H: 1.24%
C: 0.37%
JNJ | News | $149.56 0.3% -0.17% 6.9M
|
Health Technology
|
| O: 0.47%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: -0.17%
H: 0.0%
C: 0.0%
fda
MAIA Biotechnology, Inc. Announces $2.4 Million Financing to Advance Targeted Immuno-Oncology Studies
Published: 2022-03-16 (Crawled : 12:30) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
technology biotech iot
Clinical Catch-Up: Pfizer's Paxlovid, Immunome Set and Gilead's Trodelvy
Published: 2022-03-14 (Crawled : 12:30) - biospace.com/
SNYNF | News | $94.25 1.67% -2.18% 480
|
Health Technology
|
| O: -2.53%
H: 0.0%
C: -0.08%
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: -3.24%
H: 0.0%
C: 0.0%
trodelvy set
DarioHealth Enters into Strategic Agreement with Sanofi U.S.
Published: 2022-03-01 (Crawled : 12:30) - prnewswire.com
SNYNF | News | $94.25 1.67% -2.18% 480
|
Health Technology
|
| O: -3.33%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: -1.3%
H: 0.0%
C: 0.0%
DRIO | $1.45 9.85% 13.16% 160K
|
Health Technology
|
| O: 9.38%
H: 1.26%
C: -3.4%
health
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
ZAPP | $4.44 50.2% 33.12% 370K
|
n/a
MTC | $2.24 43.59% 30.67% 6M
|
Technology Services
OPRT | News | $3.15 40.0% 29.13% 12M
|
Finance
SHIM | $3.045 35.33% 26.23% 870K
|
HKIT | $1.33 30.39% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
OST | $0.5 25.0% 21.88% 280K
|
Your saved searches
Save your searches and get alerts when important news are released.